Clinical Trials Directory

Trials / Sponsors / Knopp Biosciences

Knopp Biosciences

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedDexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
Eosinophilic Asthma, Asthma
Phase 22019-08-15
CompletedStudy of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
Chronic Sinusitis With Nasal Polyps and Eosinophilia
Phase 22014-08-01
CompletedStudy in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects
Healthy Volunteers
Phase 12012-06-01
TerminatedPhase 3 Extension Study of Dexpramipexole in ALS
Amyotrophic Lateral Sclerosis
Phase 32012-06-01
CompletedDexpramipexole and Warfarin Drug Drug Interaction (DDI) Study
Healthy Volunteers
Phase 12012-05-01
CompletedDexpramipexole and Cimetidine Drug Drug Interaction (DDI)
Amyotrophic Lateral Sclerosis
Phase 12012-03-01
CompletedStudy to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (E
Amyotrophic Lateral Sclerosis
Phase 12012-01-01
CompletedDexpramipexole SAD/MAD Study
Amyotrophic Lateral Sclerosis
Phase 12011-11-01
CompletedDexpramipexole Japanese PK Study
Amyotrophic Lateral Sclerosis
Phase 12011-08-01
CompletedDexpramipexole Renal PK Study
Amyotrophic Lateral Sclerosis, Renal Insufficiency
Phase 12011-07-01
CompletedPhase 3 Study of Dexpramipexole in ALS
Amyotrophic Lateral Sclerosis
Phase 32011-03-01
CompletedOpen-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL21
Amyotrophic Lateral Sclerosis
Phase 22009-07-01
CompletedSafety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Phase 22008-04-09